Cookies

Our website uses cookies and other similar tools. We also analyze anonymized web traffic. You can choose your cookie preferences below. You may choose only necessary cookies, specific cookies or all cookies. Read more in our privacy policy

Home > Market Access

Our Market Access services help pharmaceutical companies bring their drugs to the right patients at the right time and at the right price.

Ota yhteyttä!

We assist pharmaceutical companies in bringing a new drug to the right patient group promptly and at an optimal price. Our support is always available for Market Access experts, managers, directors, and business units, whether it involves evaluating healthcare interventions, health economic modeling, pricing and reimbursement applications, risk-sharing agreements and models, or market analytics.

What makes our Market Access services unique?

Medaffcon is a full-service provider in Market Access as well. In our services, we offer strategic and tactical advice and expert services, especially for pharmaceutical companies, covering all phases of market entry and subsequent phases of the product lifecycle.

The goal of Market Access activities is to ensure that new technology, such as a drug, reaches the right patient group as quickly as possible after obtaining marketing authorization at a price that is optimal for healthcare providers, payers, and the marketing authorization holder. This activity aims to mitigate or remove non-medical barriers to the use of technology.

Medaffcon excels in the evaluation of healthcare methods, health economic modeling, pricing and reimbursement applications, interactive tools and calculators, risk-sharing models, and market analysis based on real-life data.

We have carried out dozens of access projects annually for 15 years, which gives us a broad and insightful expertise. Our active collaboration with authorities, like Fimea and the Pharmaceuticals Pricing Board, and the scientific community ensures that our information is up-to-date and that we can consider the challenges and perspectives of all stakeholders.

Our experts work closely with clients’ Market Access directors, managers, and specialists, as well as business accountables. We provide knowledgeable support, whether it involves the drug pricing and reimbursement application process, strategic market entry planning, or current trends in the pharmaceutical industry.

Why choose us for Market Access projects?

Expert Solutions

We take on an expert role and operate solution-focused throughout all stages of market access projects.

Reliability

We are reliable and honest. We do not overpromise and address critical issues in a timely manner. We advocate for our clients and avoid unnecessary work.

Strong Local Expertise and Experience

We are familiar with the local operational environment and national peculiarities, which leads to a smooth Market Access process.

Client Promise

In our Market Access services, we offer pharmaceutical companies strategic and tactical advice and expert services for all phases of market entry and subsequent phases of the product lifecycle.

Our long experience in Market Access, reliability, and dedication to client needs have led to high customer satisfaction. Our NPS (Net Promoter Score) for Access services is over 70.

Our Market Access services

Contact us!

Related articles

Simo Jääskeläinen

Simo Jääskeläinen

Market Access Lead

MSc (Health Sciences), BBA

Simo started as the leader of Medaffcon’s Market Access team in November 2024. He is a returnee, as he has also previously worked at Medaffcon. Before returning to Medaffcon, Simo worked in a pharmaceutical company as the head of a Market Access team and has also gained Market Access experience in other pharmaceutical companies. He has over 20 years of experience in the pharmaceutical industry. Simo holds a Master’s degree in Health Sciences and a Bachelor’s degree in Business Administration.

Simo brings to Medaffcon a strong and versatile background in the pharmaceutical industry, particularly in Market Access roles. His strengths include versatility, organizational skills, and the ability to see the bigger picture. In the field of Market Access, Simo does not consider himself an expert in any particular subfield but sees himself as a generalist. He is drawn to the challenges of the industry and the opportunity to find comprehensive solutions that meet the needs of clients.

Ongoing changes in the operating environment require pharmaceutical companies to adapt and adopt new ways of working. Simo believes that the role and importance of Market Access will become even more prominent in a situation where society’s willingness to pay and the needs of the pharmaceutical industry must be aligned in a way that benefits both parties.

Jarmo Hahl

Jarmo Hahl

Principal Consultant

MSc (Economics)

+358 40 139 4001

Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.

Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.

“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.

Tomi Vahevaara

Tomi Vahevaara

Sales Lead

eMBA

+358 50 305 5963

Tomi Vahevaara started working at Medaffcon in January 2017 as a Sales Director. He has been working in the pharmaceutical industry for over 35 years. Therefore, he has gained wide-ranging experience in international expert and managerial positions within the innovative pharmaceutical industry. Before joining Medaffcon, Tomi worked for ten years as the Managing Director of Eli Lilly for Finland, the Baltic States, and Poland.

Tomi has solid and wide-ranging expertise in different positions in the pharmaceutical field and is well connected in the entire health industry network. He serves as the Chairman of the Board of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities and as a Board Member in the Finnish Co-operative for Pharmaceutical Injury Indemnities. Tomi is particularly interested in the significant economic and investment opportunities for Finland and those companies working in the Finnish health industry.